Efficacy of Digital Cognitive Behavioral Therapy for Insomnia (CBT-I)
1 other identifier
interventional
168
1 country
1
Brief Summary
Insomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the efficacy of an app-based CBT-I with AI chatbot in reducing insomnia symptoms among youths, compared to an app-based CBT-I without AI chatbot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 26, 2024
CompletedFirst Submitted
Initial submission to the registry
August 18, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
March 18, 2026
March 1, 2026
1.9 years
August 18, 2024
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index
the severity of insomnia symptoms
a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
Secondary Outcomes (14)
sleep onset latency (SOL)
a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
wake after sleep onset (WASO)
a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
sleep efficiency (SE)
a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
Total sleep time (TST)
a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
The Pre-Sleep Arousal Scale
a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)
- +9 more secondary outcomes
Other Outcomes (4)
Treatment Satisfaction Scale
post-intervention (1-month after baseline)
Treatment Component Adherence
post-intervention (1-month after baseline)
Acceptability E-scale questionnaire
post-intervention (1-month after baseline)
- +1 more other outcomes
Study Arms (2)
app-based digital cognitive behavioral therapy for insomnia with AI chatbot
EXPERIMENTALapp-based digital cognitive behavioral therapy for insomnia without AI chatbot
ACTIVE COMPARATORInterventions
digital cognitive behavioral therapy for insomnia with two-way interactive, intelligent, and patient-centered conversational agents
digital cognitive behavioral therapy for insomnia without two-way interactive, intelligent, and patient-centered conversational agents
Eligibility Criteria
You may qualify if:
- i. Youth aged 18 to 25 years (as defined by WHO and evidence on AI mental health chatbots only available for individuals aged 18 years and older)
- ii. Online informed consent of participation in the study should be provided
- iii. Willing to comply with the requirements of the study protocol
- iv. The presence of moderate to severe insomnia measured by a score of 15 or above on the Insomnia Severity Index (ISI)
- v. difficulties initiating, maintaining or nonrestorative sleep over a 1-month period
- vi. Having access to a smartphone and consistent internet access for their smartphone
- vii. Accepting the terms of service and privacy policies of the mobile apps used in the study for the delivery of the intervention
You may not qualify if:
- i. A history of any sleep disorder(s) (other than insomnia disorder) such as narcolepsy, obstructive sleep apnea, and restless legs syndrome
- ii. A history of any mental retardation or neuropsychiatric disorder(s) (other than depression and anxiety disorders as they are the secondary outcomes) such as bipolar disorder, schizophrenia, and substance use disorder
- iii. Presence of serious suicidality as evidenced by ideation with a plan or an attempt
- iv. Receiving any pharmacological treatment (including sleep promoting agents)
- v. Receiving any structured psychotherapy
- vi. Having shiftwork and trans-meridian travel in the past 3 months and during the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, the Chinese University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
August 18, 2024
First Posted
September 19, 2024
Study Start
July 26, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03